CEBP 09 AM Call for Abstracts w/deadline 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Epidemiology Biomarkers & Prevention 16, 2509-2512, November 1, 2007. doi: 10.1158/1055-9965.EPI-07-0530
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagata, C.
Right arrow Articles by Shimizu, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagata, C.
Right arrow Articles by Shimizu, H.
Related Collections
Right arrow Epidemiology
Right arrow Epidemiology: Biomarkers

Short Communication

Urinary 6-Sulfatoxymelatonin and Mammographic Density in Japanese Women

Chisato Nagata1, Tomoko Matsubara6, Takeshi Hara2, Hiroshi Fujita2, Yasuko Nagao3, Satoru Yamamoto3, Chiken Shibuya3, Yoshitomo Kashiki3,4 and Hiroyuki Shimizu1,5

1 Department of Epidemiology and Preventive Medicine and 2 Intelligence Image Information, Gifu University Graduate School of Medicine; 3 Gihoku General Hospital; 4 Asahi University School of Dentistry; 5 Sakihai Institute, Gifu, Japan and 6 Department of Information Culture, Nagoya Bunri University, Aichi, Japan

Requests for reprints: Chisato Nagata, Department of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. Phone: 81-58-230-6411; Fax: 81-58-230-6413. E-mail: chisato{at}gifu-u.ac.jp

A protective role of melatonin in the etiology of breast cancer has been suggested. The down-regulation of estrogen secretion by melatonin is thought to be a main cause of the link between melatonin and breast cancer risk. The present cross-sectional study examined whether the urinary 6-sulfatoxymelatonin (aMT6-s) level is inversely associated with mammographic density, which is regarded as a marker of breast cancer risk. The study subjects were 289 Japanese women (175 premenopausal and 123 postmenopausal women) who were recruited from participants in a mammographic breast cancer screening. The size of the total breast area and that of the dense area were measured quantitatively using an automated mammographic mass detection method. The concentration of aMT6-s was measured using first-void morning urine. In premenopausal women, the urinary aMT6-s level was significantly positively associated with percent density after controlling for covariates (P for trend = 0.02). There was no significant association between urinary aMT6-s level and the percent density in postmenopausal women. We found no evidence that the melatonin level is inversely associated with mammographic density. (Cancer Epidemiol Biomarkers Prev 2007;16(11):2509–12)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.